Our results showed that B[a]P had no effect on HCC cell morphology or growth; however, B[a]P treatment significantly promoted cell migration and invasion, enhanced recruitment of vascular endothelial cells and tumor angiogenesis, activated NF-κB signaling, and elevated VEGF secretion. The gene discussed is VEGFA; the disease is neoplasm.